IOL Selection in Glaucoma Patient

趙世鈞 Shih-Chun ChaoTaiwan Speaker IOL Selection in Glaucoma PatientIn patients with both cataract and glaucoma, intraocular lens (IOL) selection is a critical decision that must balance visual enhancement with long-term disease stability. While premium IOLs—such as multifocal, extended depth of focus (EDOF), accommodative, toric, and aspheric lenses—offer advantages like improved spectacle independence and enhanced intermediate vision, their benefits must be weighed against the unique challenges posed by glaucomatous eyes. Ultimately, IOL selection should be highly individualized. Patients with glaucoma suspect, ocular hypertension, or stable early glaucoma may benefit from certain types of premium lenses, while those with moderate-to-severe disease should prioritize visual quality and safety over spectacle independence. Other factors such as ocular surface disease, pupil reactivity, type of glaucoma surgery, and biometric stability must all be carefully considered to optimize outcomes.